Get started
Author

Andreas J. Melidonis

Observed names: A Melidonis, A. Melidonis, ANDREAS J. MELIDONIS, ANDREAS MELIDONIS, Andreas Melidonis, Αndreas Μelidonis
ORCID: 0000-0003-0505-5708
Observed ORCID: 0000-0003-0505-5708
OpenAlex ID: A5103218300
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
2018 · Adrian F Hernandez, Jennifer B Green, et al. · The Lancet · 1,921
PDF
Type 2 diabetes and quality of life
2017 · Aikaterini Trikkalinou, Athanasia K Papazafiropoulou, et al. · World Journal of Diabetes · 644
PDF
Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus
2017 · Andrew Xanthopoulos, Gregory Giamouzis, et al. · Cardiovascular Diabetology · 95
Diabetes-dependent quality of life (ADDQOL) and affecting factors in patients with diabetes mellitus type 2 in Greece
2015 · Athanasia K. Papazafiropoulou, Florentia Bakomitrou, et al. · BMC Research Notes · 59
PDF
Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns
2020 · Chrysi Koliaki, Anastasios Tentolouris, et al. · Journal of Clinical Medicine · 56
PDF
Prediction of long-term functional outcome in patients with acute ischemic non-embolic stroke
2008 · John Protopsaltis, Stelios Kokkoris, et al. · Atherosclerosis · 46
Heart rate variability in advanced chronic kidney disease with or without diabetes: midterm effects of the initiation of chronic haemodialysis therapy
2010 · M. Mylonopoulou, N. Tentolouris, et al. · Nephrology Dialysis Transplantation · 45
The Problem Areas in Diabetes (PAID) scale: psychometric evaluation survey in a Greek sample with type 2 diabetes
2012 · A. Papathanasiou, A. Koutsovasilis, et al. · Journal of Psychiatric and Mental Health Nursing · 41
Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
2016 · Apostolos Achimastos, Theodoras Alexandrides, et al. · HORMONES · 33
PDF
Circulating microRNAs as biomarkers for diabetic neuropathy: A novel approach
2018 · Eleni Xourgia, Athanasia Papazafiropoulou, et al. · World Journal of Experimental Medicine · 31
Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece
2014 · Charalampos Tzanetakos, Andreas Melidonis, et al. · BMC Health Services Research · 30
PDF
Antidiabetic treatment on memory and spatial learning: From the pancreas to the neuron
2019 · Eleni Xourgia, Athanasia Papazafiropoulou, et al. · World Journal of Diabetes · 26
PDF
Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel‐Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events
2020 · Kallirroi Kalantzi, Nikolaos Tentolouris, et al. · Journal of the American Heart Association · 24
PDF
Comparative Performance of Three Metabolic Syndrome Definitions in the Prediction of Acute Coronary Syndrome
2009 · Anastasios Koutsovasilis, John Protopsaltis, et al. · Internal Medicine · 24
PDF
Effects of antidiabetic drugs on epicardial fat
2018 · Eleni Xourgia, Athanasia Papazafiropoulou, et al. · World Journal of Diabetes · 22
PDF
Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry
2020 · Kyriakos Souliotis, Anastasios Koutsovasilis, et al. · BMC Endocrine Disorders · 20
PDF
The Real-Life Effectiveness and Care Patterns of Type 2 Diabetes Management in Greece
2017 · Emmanuel Pagkalos, Anastasia Thanopoulou, et al. · Experimental and Clinical Endocrinology & Diabetes · 19
Metabolic syndrome and its components as predictors of all-cause mortality and coronary heart disease in type 2 diabetic patients
2006 · Ioannis Protopsaltis, Georgios Nikolopoulos, et al. · Atherosclerosis · 17
Effects of Glucagon-like Peptide-1 Receptor Agonists and Sodium-glucose Cotransporter 2 Inhibitors on Cardiorenal and Metabolic Outcomes in People Without Diabetes
2020 · Athanasia K. Papazafiropoulou, Andreas Melidonis, et al. · Current Pharmaceutical Design · 16
Influence of Supervised Disease Understanding and Diabetes Self-Management on Adherence to Oral Glucose-Lowering Treatment in Patients with Type 2 Diabetes
2019 · John Doupis, Theodoros Alexandrides, et al. · Diabetes Therapy · 15
PDF
Management of type 2 diabetes and its prescription drug cost before and during the economic crisis in Greece: an observational study
2014 · Stavros Liatis, Stavroula Papaoikonomou, et al. · BMC Endocrine Disorders · 14
PDF
Impact of the metabolic syndrome and its components combinations on arterial stiffness in Type 2 diabetic men.
2009 · D Levisianou, A Melidonis, et al. · PubMed · 14
The Oral Dipeptidyl-Peptidase-4 Inhibitor Sitagliptin Increases Circulating Levels Of Stromal-Derived Factor-1 Alpha
2017 · Athanasia Papazafiropoulou, Nikolaos Papanas, et al. · Experimental and Clinical Endocrinology & Diabetes · 13
Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals
2014 · S. Liatis, M. Mylona, et al. · Diabetes & Metabolism · 13
Reporting distress and quality of life of patients with diabetes mellitus in primary and secondary care in Greece.
2008 · Athanasia Papathanasiou, Sue Shea, et al. · PubMed · 12
Works count: 67
Citation count: 3,396
H-index: 17
I10-index: 31
Year
Topic
Type